{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T02:21:10Z","timestamp":1793154070941,"version":"4.5.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T00:00:00Z","timestamp":1663804800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T00:00:00Z","timestamp":1663804800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Heroin pipe distribution may encourage people who use heroin (PWUH) to transition from injecting to smoking heroin, reducing harms associated with injection drug use. A syringe services program (SSP) in Seattle, Washington, led by people who use drugs developed a heroin pipe distribution program.\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We conducted a pretest\u2013posttest quasi-experimental study to evaluate the impact of heroin pipe distribution on drug consumption behaviors among PWUH between March and December 2019. SSP clients were surveyed during three weeklong timepoints before and four weeklong timepoints after heroin pipe distribution. Primary outcomes were change in proportion of SSP clients who exclusively injected heroin, exclusively smoked heroin, and both injected and smoked heroin in the past seven days comparing the pre- and post-intervention periods.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Across the seven observation timepoints, 694 unique respondents completed 957 surveys. Multiple responses from a single respondent in a given period were collapsed, resulting in 360 pre-intervention and 430 post-intervention records. Heroin use was reported in over half of pre-intervention (56%, 201\/360) and post-intervention records (58%, 251\/430). Compared to pre-intervention behaviors, the proportion of respondents who exclusively injected heroin was lower after the start of heroin pipe distribution (32%, 80\/251 vs 43%, 86\/201, <jats:italic>p<\/jats:italic>\u2009=\u20090.02), while the proportion of respondents who both injected and smoked heroin was higher (45%, 113\/251 vs 36%, 72\/201, <jats:italic>p<\/jats:italic>\u2009=\u20090.048). Just under half (44%, 110\/251) of respondents who used heroin during the post-intervention period used a heroin pipe obtained from the SSP, of which 34% (37\/110) reported heroin pipe distribution had reduced their heroin injection frequency. Self-reported hospitalization for a pulmonary cause was not associated with using a heroin pipe.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The proportion of SSP clients who exclusively injected heroin was lower after implementation of heroin pipe distribution. Randomized studies with longer follow-up are needed to investigate whether heroin pipe distribution reduces heroin injection and improves health outcomes associated with drug use. Limited intervention exposure, loss to follow-up, and pipe availability from other sources pose methodological challenges to evaluations of route transition interventions in community settings. This pilot highlights the potential for organizations led by people who use drugs to develop, implement, and evaluate novel public health programming.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12954-022-00685-7","type":"journal-article","created":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T08:04:15Z","timestamp":1663833855000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Heroin pipe distribution to reduce high-risk drug consumption behaviors among people who use heroin: a pilot quasi-experimental study"],"prefix":"10.1186","volume":"19","author":[{"given":"Thomas","family":"Fitzpatrick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa M.","family":"McMahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noah D.","family":"Frank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara N.","family":"Glick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren R.","family":"Violette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shantel","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shilo","family":"Jama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,22]]},"reference":[{"issue":"2","key":"685_CR1","doi-asserted-by":"publisher","first-page":"102","DOI":"10.2471\/BLT.12.108282","volume":"91","author":"BM Mathers","year":"2013","unstructured":"Mathers BM, Degenhardt L, Bucello C, Lemon J, Wiessing L, Hickman M. Mortality among people who inject drugs: a systematic review and meta-analysis. Bull World Health Organ. 2013;91(2):102\u201323.","journal-title":"Bull World Health Organ"},{"issue":"2","key":"685_CR2","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s11904-018-0390-3","volume":"15","author":"DC Perlman","year":"2018","unstructured":"Perlman DC, Jordan AE. The syndemic of opioid misuse, overdose, HCV, and HIV: structural-level causes and interventions. Curr HIV\/AIDS Rep. 2018;15(2):96\u2013112.","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"1","key":"685_CR3","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jhep.2012.08.024","volume":"58","author":"KB Kielland","year":"2013","unstructured":"Kielland KB, Skaug K, Amundsen EJ, Dalgard O. All-cause and liver-related mortality in hepatitis C infected drug users followed for 33 years: a controlled study. J Hepatol. 2013;58(1):31\u20137.","journal-title":"J Hepatol"},{"key":"685_CR4","doi-asserted-by":"crossref","unstructured":"Wurcel AG, Anderson JE, Chui KK, Skinner S, Knox TA, Snydman DR, et al. Increasing infectious endocarditis admissions among young people who inject drugs. Open Forum Infect Dis. 2016;3(3): 157.","DOI":"10.1093\/ofid\/ofw157"},{"key":"685_CR5","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.drugalcdep.2016.04.009","volume":"163","author":"D Ciccarone","year":"2016","unstructured":"Ciccarone D, Unick GJ, Cohen JK, Mars SG, Rosenblum D. Nationwide increase in hospitalizations for heroin-related soft tissue infections: associations with structural market conditions. Drug Alcohol Depend. 2016;163:126\u201333.","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"685_CR6","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1080\/10550887.2011.581989","volume":"30","author":"SP Novak","year":"2011","unstructured":"Novak SP, Kral AH. Comparing injection and non-injection routes of administration for heroin, methamphetamine, and cocaine users in the United States. J Addict Dis. 2011;30(3):248\u201357.","journal-title":"J Addict Dis"},{"issue":"3","key":"685_CR7","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1080\/10826084.2019.1683198","volume":"55","author":"D Toro-Tob\u00f3n","year":"2020","unstructured":"Toro-Tob\u00f3n D, Berbesi-Fern\u00e1ndez D. Prevalence of HIV\/Hepatitis C virus co-infection and injection risk correlations in people who inject drugs in colombia: a cross-sectional study using respondent driven sampling. Subst Use Misuse. 2020;55(3):414\u201323.","journal-title":"Subst Use Misuse"},{"key":"685_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2020.108080","volume":"213","author":"J Doran","year":"2020","unstructured":"Doran J, Harris M, Hope VD, Wright T, Edmundson C, Sinka K, et al. Factors associated with skin and soft tissue infections among people who inject drugs in the United Kingdom: a comparative examination of data from two surveys. Drug Alcohol Depend. 2020;213: 108080.","journal-title":"Drug Alcohol Depend"},{"key":"685_CR9","doi-asserted-by":"publisher","first-page":"205031211774098","DOI":"10.1177\/2050312117740987","volume":"5","author":"O Olubamwo","year":"2017","unstructured":"Olubamwo O, Onyeka IN, Aregbesola A, Ronkainen K, Tiihonen J, F\u00f6hr J, et al. Association between route of illicit drug administration and hospitalizations for infective endocarditis. SAGE Open Med. 2017;5:2050312117740987.","journal-title":"SAGE Open Med"},{"issue":"7054","key":"685_CR10","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1136\/bmj.313.7054.402","volume":"313","author":"M Gossop","year":"1996","unstructured":"Gossop M, Griffiths P, Powis B, Williamson S, Strang J. Frequency of non-fatal heroin overdose: survey of heroin users recruited in non-clinical settings. BMJ. 1996;313(7054):402.","journal-title":"BMJ"},{"issue":"1","key":"685_CR11","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/j.1360-0443.2010.03140.x","volume":"106","author":"L Degenhardt","year":"2011","unstructured":"Degenhardt L, Bucello C, Mathers B, Briegleb C, Ali H, Hickman M, et al. Mortality among regular or dependent users of heroin and other opioids: a systematic review and meta-analysis of cohort studies. Addiction. 2011;106(1):32\u201351.","journal-title":"Addiction"},{"key":"685_CR12","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s12909-015-0487-y","volume":"15","author":"J Klimas","year":"2015","unstructured":"Klimas J, Egan M, Tobin H, Coleman N, Bury G. Development and process evaluation of an educational intervention for overdose prevention and naloxone distribution by general practice trainees. BMC Med Educ. 2015;15:206.","journal-title":"BMC Med Educ"},{"issue":"6","key":"685_CR13","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1093\/jat\/18.6.317","volume":"18","author":"AJ Jenkins","year":"1994","unstructured":"Jenkins AJ, Keenan RM, Henningfield JE, Cone EJ. Pharmacokinetics and pharmacodynamics of smoked heroin. J Anal Toxicol. 1994;18(6):317\u201330.","journal-title":"J Anal Toxicol"},{"issue":"1","key":"685_CR14","doi-asserted-by":"publisher","first-page":"109","DOI":"10.2174\/157488406775268219","volume":"1","author":"EJ Rook","year":"2006","unstructured":"Rook EJ, Huitema AD, van den Brink W, van Ree JM, Beijnen JH. Pharmacokinetics and pharmacokinetic variability of heroin and its metabolites: review of the literature. Curr Clin Pharmacol. 2006;1(1):109\u201318.","journal-title":"Curr Clin Pharmacol"},{"issue":"1","key":"685_CR15","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s12954-019-0312-8","volume":"16","author":"S Islam","year":"2019","unstructured":"Islam S, Piggott DA, Moriggia A, Astemborski J, Mehta SH, Thomas DL, et al. Reducing injection intensity is associated with decreased risk for invasive bacterial infection among high-frequency injection drug users. Harm Reduct J. 2019;16(1):38.","journal-title":"Harm Reduct J"},{"issue":"1","key":"685_CR16","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s12889-017-4099-9","volume":"17","author":"A Prangnell","year":"2017","unstructured":"Prangnell A, Dong H, Daly P, Milloy MJ, Kerr T, Hayashi K. Declining rates of health problems associated with crack smoking during the expansion of crack pipe distribution in vancouver, Canada. BMC Public Health. 2017;17(1):163.","journal-title":"BMC Public Health"},{"issue":"4","key":"685_CR17","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1080\/10826084.2018.1528460","volume":"54","author":"J Frankeberger","year":"2019","unstructured":"Frankeberger J, Cepeda A, Natera-Rey G, Valdez A. Safer crack kits and smoking practices: effectiveness of a harm reduction intervention among active crack users in Mexico City. Subst Use Misuse. 2019;54(4):592\u2013600.","journal-title":"Subst Use Misuse"},{"key":"685_CR18","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1477-7517-9-9","volume":"9","author":"C Hunter","year":"2012","unstructured":"Hunter C, Strike C, Barnaby L, Busch A, Marshall C, Shepherd S, et al. Reducing widespread pipe sharing and risky sex among crystal methamphetamine smokers in Toronto: do safer smoking kits have a potential role to play? Harm Reduct J. 2012;9:9.","journal-title":"Harm Reduct J"},{"issue":"3","key":"685_CR19","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.drugpo.2007.02.008","volume":"19","author":"L Leonard","year":"2008","unstructured":"Leonard L, DeRubeis E, Pelude L, Medd E, Birkett N, Seto J. \u201cI inject less as I have easier access to pipes\u201d: injecting, and sharing of crack-smoking materials, decline as safer crack-smoking resources are distributed. Int J Drug Policy. 2008;19(3):255\u201364.","journal-title":"Int J Drug Policy"},{"key":"685_CR20","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1747-597X-6-34","volume":"6","author":"L Ti","year":"2011","unstructured":"Ti L, Buxton J, Wood E, Zhang R, Montaner J, Kerr T. Difficulty accessing crack pipes and crack pipe sharing among people who use drugs in vancouver. Canada Subst Abuse Treat Prev Policy. 2011;6:34.","journal-title":"Canada Subst Abuse Treat Prev Policy"},{"issue":"4","key":"685_CR21","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1080\/09595239996310","volume":"18","author":"N Hunt","year":"1999","unstructured":"Hunt N, Griffiths P, Southwell M, Stillwell G, Strang J. Preventing and curtailing injecting drug use: a review of opportunities for developing and delivering \u2018route transition interventions.\u2019 Drug Alcohol Rev. 1999;18(4):441\u201351.","journal-title":"Drug Alcohol Rev"},{"issue":"1","key":"685_CR22","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12954-017-0144-3","volume":"14","author":"C Strike","year":"2017","unstructured":"Strike C, Watson TM. Education and equipment for people who smoke crack cocaine in Canada: progress and limits. Harm Reduct J. 2017;14(1):17.","journal-title":"Harm Reduct J"},{"key":"685_CR23","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1477-7517-11-18","volume":"11","author":"HJ St\u00f6ver","year":"2014","unstructured":"St\u00f6ver HJ, Sch\u00e4ffer D. SMOKE IT! Promoting a change of opiate consumption pattern - from injecting to inhaling. Harm Reduct J. 2014;11:18.","journal-title":"Harm Reduct J"},{"issue":"6","key":"685_CR24","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1111\/add.14914","volume":"115","author":"S Imtiaz","year":"2020","unstructured":"Imtiaz S, Strike C, Elton-Marshall T, Rehm J. Safer smoking kits for methamphetamine consumption. Addiction. 2020;115(6):1189\u201390.","journal-title":"Addiction"},{"issue":"7","key":"685_CR25","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1080\/02770903.2016.1259420","volume":"54","author":"TH Self","year":"2017","unstructured":"Self TH, Shah SP, March KL, Sands CW. Asthma associated with the use of cocaine, heroin, and marijuana: a review of the evidence. J Asthma. 2017;54(7):714\u201322.","journal-title":"J Asthma"},{"issue":"3","key":"685_CR26","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0163-4453(96)80017-X","volume":"32","author":"GH Mientjes","year":"1996","unstructured":"Mientjes GH, Spijkerman IJ, van Ameijden EJ, van den Hoek JA, Coutinho RA. Incidence and risk factors for pneumonia in HIV infected and non-infected drug users. J Infect. 1996;32(3):181\u20136.","journal-title":"J Infect"},{"issue":"2","key":"685_CR27","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)\u2013a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377\u201381.","journal-title":"J Biomed Inform"},{"key":"685_CR28","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1477-7517-5-24","volume":"5","author":"R Pizzey","year":"2008","unstructured":"Pizzey R, Hunt N. Distributing foil from needle and syringe programmes (NSPs) to promote transitions from heroin injecting to chasing: an evaluation. Harm Reduct J. 2008;5:24.","journal-title":"Harm Reduct J"},{"issue":"3","key":"685_CR29","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1111\/1471-0528.15195","volume":"126","author":"K Hemming","year":"2019","unstructured":"Hemming K, Girling A. Cluster randomised trials: useful for interventions delivered to groups: study design: cluster randomised trials. BJOG. 2019;126(3):340.","journal-title":"BJOG"},{"issue":"11","key":"685_CR30","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1001\/jamaneurol.2018.1693","volume":"75","author":"V Alambyan","year":"2018","unstructured":"Alambyan V, Pace J, Miller B, Cohen ML, Gokhale S, Singh G, et al. The emerging role of inhaled heroin in the opioid epidemic: a review. JAMA Neurol. 2018;75(11):1423\u201334.","journal-title":"JAMA Neurol"},{"issue":"1","key":"685_CR31","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12954-022-00624-6","volume":"19","author":"A Hrycko","year":"2022","unstructured":"Hrycko A, Mateu-Gelabert P, Ciervo C, Linn-Walton R, Eckhardt B. Severe bacterial infections in people who inject drugs: the role of injection-related tissue damage. Harm Reduct J. 2022;19(1):41.","journal-title":"Harm Reduct J"},{"key":"685_CR32","first-page":"201","volume":"173","author":"Y Meng","year":"1997","unstructured":"Meng Y, Lichtman AH, Bridgen DT, Martin BR. Inhalation studies with drugs of abuse. NIDA Res Monogr. 1997;173:201\u201324.","journal-title":"NIDA Res Monogr"},{"issue":"4","key":"685_CR33","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1001\/jamaneurol.2019.0183","volume":"76","author":"D Ciccarone","year":"2019","unstructured":"Ciccarone D. Heroin smoking is not common in the United States. JAMA Neurol. 2019;76(4):508.","journal-title":"JAMA Neurol"},{"key":"685_CR34","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.drugpo.2019.04.010","volume":"70","author":"M Zoorob","year":"2019","unstructured":"Zoorob M. Fentanyl shock: the changing geography of overdose in the United States. Int J Drug Policy. 2019;70:40\u20136.","journal-title":"Int J Drug Policy"},{"key":"685_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.109003","volume":"227","author":"AH Kral","year":"2021","unstructured":"Kral AH, Lambdin BH, Browne EN, Wenger LD, Bluthenthal RN, Zibbell JE, et al. Transition from injecting opioids to smoking fentanyl in San Francisco. California Drug Alcohol Depend. 2021;227: 109003.","journal-title":"California Drug Alcohol Depend"},{"issue":"1","key":"685_CR36","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/s41398-019-0625-0","volume":"9","author":"Y Han","year":"2019","unstructured":"Han Y, Yan W, Zheng Y, Khan MZ, Yuan K, Lu L. The rising crisis of illicit fentanyl use, overdose, and potential therapeutic strategies. Transl Psychiatry. 2019;9(1):282.","journal-title":"Transl Psychiatry"}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-022-00685-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12954-022-00685-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-022-00685-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T00:08:10Z","timestamp":1663891690000},"score":1,"resource":{"primary":{"URL":"https:\/\/harmreductionjournal.biomedcentral.com\/articles\/10.1186\/s12954-022-00685-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,22]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["685"],"URL":"https:\/\/doi.org\/10.1186\/s12954-022-00685-7","relation":{},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,22]]},"assertion":[{"value":"25 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The University of Washington Institutional Review Board approved this study (#00006488). Informed consent was obtained from all participants before beginning their first survey.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"TF serves as a volunteer on the board of directors, and VM and SD were previously employed by The People\u2019s Harm Reduction Alliance during the time period when this study was conducted. The authors declare they have no other competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"103"}}